Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M46,311Revenue (TTM) $M10,706Net Margin (%)--Altman Z-Score--
Enterprise Value $M--EPS (TTM) $3.9Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.3PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %43.0Shares Outstanding M453ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with COV

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
COVDavid Einhorn 2014-12-31 Buy 1.2%$82.2 - $104.06
($96)
$ 106.7111%New holding851,341
COVHOTCHKIS & WILEY 2014-12-31 Add0.07%$82.2 - $104.06
($96)
$ 106.7111%Add 28.50%935,100
COVMario Gabelli 2014-12-31 Reduce-0.05%$82.2 - $104.06
($96)
$ 106.7111%Reduce -22.30%359,176
COVJohn Paulson 2014-09-30 Add2%$82.54 - $91.76
($88.57)
$ 106.7120%Add 79.93%12,595,000
COVPrivate Capital 2014-09-30 Reduce-0.85%$82.54 - $91.76
($88.57)
$ 106.7120%Reduce -33.88%157,828
COVGeorge Soros 2014-09-30 Sold Out -0.15%$82.54 - $91.76
($88.57)
$ 106.7120%Sold Out0
COVMario Gabelli 2014-09-30 Reduce-0.08%$82.54 - $91.76
($88.57)
$ 106.7120%Reduce -27.49%462,251
COVJohn Paulson 2014-06-30 Buy 2.7%$69.03 - $91.24
($74.56)
$ 106.7143%New holding7,000,000
COVBill Nygren 2014-06-30 Reduce-1.51%$69.03 - $91.24
($74.56)
$ 106.7143%Reduce -94.09%160,000
COVRobert Olstein 2014-06-30 Sold Out -0.95%$69.03 - $91.24
($74.56)
$ 106.7143%Sold Out0
COVYacktman Focused Fund 2014-06-30 Sold Out -0.62%$69.03 - $91.24
($74.56)
$ 106.7143%Sold Out0
COVYacktman Fund 2014-06-30 Sold Out -0.56%$69.03 - $91.24
($74.56)
$ 106.7143%Sold Out0
COVDonald Yacktman 2014-06-30 Sold Out -0.55%$69.03 - $91.24
($74.56)
$ 106.7143%Sold Out0
COVGeorge Soros 2014-06-30 Buy 0.15%$69.03 - $91.24
($74.56)
$ 106.7143%New holding227,000
COVJoel Greenblatt 2014-06-30 Sold Out $69.03 - $91.24
($74.56)
$ 106.7143%Sold Out0
COVJoel Greenblatt 2014-03-31 Buy $66.35 - $72.5
($69.62)
$ 106.7153%New holding3,746
COVPrivate Capital 2013-12-31 Reduce-0.8%$59.82 - $68.42
($65.08)
$ 106.7164%Reduce -36.57%244,555
COVVanguard Health Care Fund 2013-12-31 Add0.22%$59.82 - $68.42
($65.08)
$ 106.7164%Add 24.79%4,994,700
COVHOTCHKIS & WILEY 2013-12-31 Reduce-0.16%$59.82 - $68.42
($65.08)
$ 106.7164%Reduce -46.79%657,000
COVJohn Keeley 2013-12-31 Reduce-0.06%$59.82 - $68.42
($65.08)
$ 106.7164%Reduce -52.66%44,520
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

COV is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


COV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sgrignari MichaelSenior Vice President 2014-12-05Sell25,795$103.483.12view
REILLEY DENNIS HDirector 2014-12-03Sell10,521$101.395.25view
Tarnoff Michael EVice President 2014-12-01Sell8,000$100.995.66view
BROWN RICHARD G JRVice President and Controller 2014-11-17Buy5,300$94.4412.99view
Lannum Coleman N IIIVice President 2014-11-14Buy821$93.5314.09view
Clemmer James CSenior Vice President 2014-11-10Sell3,464$92.4815.39view
BRUST ROBERT HDirector 2014-11-07Sell4,000$92.0315.95view
Lannum Coleman N IIIVice President 2014-08-27Buy3,338$87.2322.33view
Lannum Coleman N IIIVice President 2014-08-26Buy1,736$87.4622.01view
Lannum Coleman N IIIVice President 2014-08-19Buy1,720$87.8221.51view

Quarterly/Annual Reports about COV:

    News about COV:

    Articles On GuruFocus.com
    Medtronic Continues to Report Solid Numbers Dec 04 2015 
    Mairs & Power Balanced Fund Q4 2014 Commentary Mar 31 2015 
    Weekly 52-Week Highs Highlight: KR, COV, VRX, NOC Feb 01 2015 
    Dravid Abrams and His Top Four Stock Picks Jan 27 2015 
    Johnson & Johnson Riding High On Ebola Vaccines Jan 21 2015 
    I think Zimmer Will Outperform S&P 500 Performance Dec 04 2014 
    Dividend Aristocrats In Focus Part 44: Medtronic Nov 23 2014 
    Third Avenue's Top Stocks as of Q3 Nov 16 2014 
    Medical Technology Company Offers Investment Opportunity Sep 25 2014 
    Gabelli Value 25 Fund Second Quarter Commentary Sep 15 2014 

    More From Other Websites
    What’s Medtronic’s Plan to Use Its Increased Cash Accessibility? Apr 08 2016
    Medtronic Earnings: Recently Launched Products And Covidien Revenues Help Post Strong Quarter Mar 02 2016
    Medtronic Is Buying Its Way to Better Stock Health Feb 29 2016
    Medtronic (MDT) to Report Q3 Earnings: What's in the Cards? Feb 25 2016
    Tyco's Tax Avoidance Machine Will Outlive Its Infamous Name Jan 25 2016
    Medtronic releases plan for spending $9.3B in freed cash Jan 11 2016
    Medtronic PLC (MDT): Double-Digit Dividend Growth for this Dividend Aristocrat Dec 16 2015
    Medtronic's Covidien deal freed up $9.3B in cash. Now, how to spend it? Dec 03 2015
    Dividend Aristocrats Part 27: Medtronic PLC (MDT) Dec 03 2015
    Medtronic's Overseas Tax Move Freed Up $9.3 Billion Dec 03 2015
    Medtronic Beats Q2 Earnings, Covidien Integration on Track Dec 03 2015
    Medtronic Notches Strong Quarter Despite FX Headwinds Dec 03 2015
    Medical device maker Medtronic's profit beats estimates Dec 03 2015
    U.S. top court rejects Covidien bid to restore patent verdict against Ethicon Nov 30 2015
    Baxter names former Covidien chief José Almeida CEO Oct 28 2015
    Medtronic: Balanced Growth in Q1, Covidien Synergy on Track Sep 07 2015
    Is There Another 25% Upside in Medtronic? Sep 04 2015
    Medtronic sales surge as rise in U.S. surgeries drives demand Sep 03 2015
    Medtronic Beats on Q1 Earnings, Covidien Synergy on Track Sep 03 2015
    Medtronic (MDT) Stock Rallies as Earnings Exceed Estimates, Jim Cramer Weighs In Sep 03 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)